DEER PARK, N.Y., Nov. 23 /PRNewswire-FirstCall/ -- Langer, Inc. (Nasdaq: GAIT, “Langer” or the “Company”) announced today that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission for an offering of 5,000,000 shares of its common stock. The Company also intends to grant an option to the underwriters to purchase up to an additional 750,000 shares of common stock to cover over-allotments, if any. Langer is offering all of the shares in this underwritten public offering.
Piper Jaffray is acting as the sole book-running manager in this offering, and Ryan Beck & Co. and Wm Smith Securities, Incorporated are acting as co-managers. When available, copies of the preliminary prospectus relating to this offering may be obtained from the Prospectus Department of Piper Jaffray & Co. (800 Nicollet Mall J12S03, Minneapolis, MN 55402-7020, Attn: Brett Weisser, telephone (612) 303-6220, fax (612) 303-1070).
A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
Langer, Inc., together with its wholly owned subsidiary Silipos Inc., is a leading provider of high quality medical products targeting the orthopedic, orthotic and prosthetic markets. In addition, the Company offers a diverse line of skincare products for the medical, therapeutic and retail markets. The Company sells its products primarily in the United States and Canada as well as in more than 30 other countries to national, regional, international and independent medical distributors and directly to healthcare professionals. Langer is based in Deer Park, New York and has additional manufacturing facilities in Niagara Falls, New York, Brea, California, Montreal, Canada, Stoke-on-Trent, England as well as sales and marketing offices in Toronto, Canada and New York, New York.
Certain matters discussed in this press release constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those projected. The Company may use words such as “anticipates,” “believes,” “plans,” “expects,” “intends,” “future” and similar expressions to identify forward-looking statements. These risks and uncertainties are described in the Company’s filings with the Securities and Exchange Commission, including the Company’s Registration Statement on Form S-1, its 2003 Form 10-K and most recently filed Form 10-Qs and Form 8-Ks.
Langer, Inc.
CONTACT: W. Gray Hudkins, Chief Operating Officer, +1-631-667-1200,ext. 226, or Joseph P. Ciavarella, Vice President and Chief Financial Officer,+1-631-667-1200, ext. 233, both of Langer, Inc.
Web site: http://www.langerinc.com/